Clinical Trials Open to People Under 18
(124 trials open to new patients)

• Acute Lymphoblastic Leukemia (15 open to new patients)
• Acute Myeloid Leukemia (5 open to new patients)
• Adrenal Cortex Carcinoma (1 open to new patients)
• ALK Fusion Protein Expression (1 open to new patients)
• ALK Gene Mutation (1 open to new patients)
• Anal Cancer (1 open to new patients)
• Anemia (1 open to new patients)
• Astrocytoma (8 open to new patients)
• Atypical Teratoid Rhabdoid Tumor (1 open to new patients)
• Autoimmune Disease (1 open to new patients)
• BCR-ABL1 Fusion Protein Expression (1 open to new patients)
• Brain Tumor (7 open to new patients)
• BRCA 1 Gene Mutation (1 open to new patients)
• BRCA 2 Gene Mutation (1 open to new patients)
• Breast Cancer (3 open to new patients)
• Cancer, General (10 open to new patients)
• Cardiovascular Disease (1 open to new patients)
• Central Nervous System Embryonal Tumor (1 open to new patients)
• Central Nervous System Neoplasm (13 open to new patients)
• Chordoma (1 open to new patients)
• Choriocarcinoma (2 open to new patients)
• CNS Tumor (1 open to new patients)
• Colon Cancer (1 open to new patients)
• Colorectal Cancer (2 open to new patients)
• Congenital Mesoblastic Nephroma (1 open to new patients)
• CTNNB1 Gene Mutation (1 open to new patients)
• Desmoid-Type Fibromatosis (1 open to new patients)
• Disease (1 open to new patients)
• Disorders of the Immune System (1 open to new patients)
• Down Syndrome (2 open to new patients)
• Endometrial Cancer (1 open to new patients)
• Ependymoma (8 open to new patients)
• Estrogen Receptor Negative (1 open to new patients)
• ETV6 Gene Rearrangement (1 open to new patients)
• Ewing Sarcoma (12 open to new patients)
• Extragonadal Embryonal Carcinoma (1 open to new patients)
• EZH2 Gene Mutation (1 open to new patients)
• Ganglioneuroblastoma (4 open to new patients)
• Germ Cell Tumor (10 open to new patients)
• Glioblastoma (7 open to new patients)
• Glioma (18 open to new patients)
• Graft Versus Host Disease (1 open to new patients)
• Heart Failure (1 open to new patients)
• Hematologic Malignancies (1 open to new patients)
• Hematological Malignancies (1 open to new patients)
• Hematopoietic Cell Transplantation (2 open to new patients)
• Hemispheric (1 open to new patients)
• Hepatoblastoma (10 open to new patients)
• Hepatocellular Carcinoma (2 open to new patients)
• Histiocytic Disorders (1 open to new patients)
• HIV/AIDS (1 open to new patients)
• HLA-A*0201 Positive Cells Present (1 open to new patients)
• Hodgkin's Lymphoma (17 open to new patients)
• IDH1 Gene Mutation (1 open to new patients)
• IDH2 Gene Mutation (1 open to new patients)
• Immunotherapy (3 open to new patients)
• Infantile Fibrosarcoma (1 open to new patients)
• Inflammatory Bowel Disease (1 open to new patients)
• Influenza (1 open to new patients)
• Inherited Abnormalities of Platelets (1 open to new patients)
• Inherited Disorders of Metabolism (1 open to new patients)
• INI1-negative Tumors (1 open to new patients)
• Intracranial Neoplasm (1 open to new patients)
• Juvenile Xanthogranuloma (1 open to new patients)
• Kidney Cancer (2 open to new patients)
• Langerhans Cell Histiocytosis (10 open to new patients)
• Leukemia (23 open to new patients)
• Liposarcoma (1 open to new patients)
• Liver Cancer (2 open to new patients)
• Locally Advanced Chordoma (1 open to new patients)
• Loss of Heterozygosity (1 open to new patients)
• Lung Cancer (3 open to new patients)
• Lung Non-Small Cell Carcinoma (1 open to new patients)
• Lung Non-Small Cell Squamous Carcinoma (1 open to new patients)
• Lymphadenopathy (1 open to new patients)
• Lymphoma (24 open to new patients)
• Lymphoproliferative Disorder (1 open to new patients)
• Malignant Central Nervous System Neoplasm (1 open to new patients)
• Malignant Germ Cell Neoplasm (1 open to new patients)
• Malignant Neoplasm (6 open to new patients)
• Malignant Rhabdoid Tumor (1 open to new patients)
• Malignant Solid Neoplasm (15 open to new patients)
• Matched Targeted Therapy (1 open to new patients)
• Medulloblastoma (11 open to new patients)
• Melanoma (4 open to new patients)
• Metastatic Chordoma (1 open to new patients)
• Minimal Residual Disease (1 open to new patients)
• Multiple Myeloma (2 open to new patients)
• Myelodysplastic Syndrome (3 open to new patients)
• Myeloproliferative Neoplasms (2 open to new patients)
• Neoplasms (3 open to new patients)
• Neoplasms by Site (1 open to new patients)
• Neuroblastoma (24 open to new patients)
• Neurofibromatosis Type 1 (2 open to new patients)
• NMYC Gene Amplification (1 open to new patients)
• Non Hodgkin Lymphoma (14 open to new patients)
• Non-Small Cell Lung Cancer (2 open to new patients)
• NTRK1 Fusion Positive (1 open to new patients)
• NTRK1 Gene Rearrangement (1 open to new patients)
• NTRK2 Fusion Positive (1 open to new patients)
• NTRK2 Gene Rearrangement (1 open to new patients)
• NTRK3 Fusion Positive (1 open to new patients)
• NTRK3 Gene Rearrangement (1 open to new patients)
• NY-ESO-1 Positive (1 open to new patients)
• Osteosarcoma (12 open to new patients)
• Ovarian Embryonal Carcinoma (1 open to new patients)
• Ovarian Tumor (2 open to new patients)
• Pediatric Cancer (1 open to new patients)
• Pediatric Central Nervous System Tumor (1 open to new patients)
• Peripheral Primitive Neuroectodermal Tumor (5 open to new patients)
• Philadelphia Chromosome Positive (1 open to new patients)
• Plexiform Neurofibroma (1 open to new patients)
• Progesterone Receptor Negative (1 open to new patients)
• Prostate Cancer (3 open to new patients)
• PSA Progression (1 open to new patients)
• Refractory Central Nervous System Neoplasm (10 open to new patients)
• Refractory Central Nervous System Tumor (1 open to new patients)
• Refractory Hepatoblastoma (4 open to new patients)
• Refractory Langerhans Cell Histiocytosis (7 open to new patients)
• Refractory Malignant Solid Neoplasm (14 open to new patients)
• Refractory Osteosarcoma (8 open to new patients)
• Relapsed Central Nervous System Tumor (1 open to new patients)
• Renal Cell Carcinoma (2 open to new patients)
• Rhabdoid Tumor (10 open to new patients)
• Rhabdomyosarcoma (12 open to new patients)
• ROS1 Fusion Positive (1 open to new patients)
• ROS1 Gene Mutation (1 open to new patients)
• Sarcoma (17 open to new patients)
• Seizures (1 open to new patients)
• Seminoma (2 open to new patients)
• Skin Cancer/Melanoma (4 open to new patients)
• SMARCA4 Gene Inactivation (1 open to new patients)
• SMARCB1 Gene Inactivation (1 open to new patients)
• SMARCB1 Gene Mutation (1 open to new patients)
• Soft Tissue Sarcoma (10 open to new patients)
• Solid Neoplasm (3 open to new patients)
• Solid Tumor (24 open to new patients)
• Spinal Column Tumor (1 open to new patients)
• Squamous Cell Carcinoma (1 open to new patients)
• Stromal Neoplasm (1 open to new patients)
• Synovial Sarcoma (1 open to new patients)
• T Cell Lymphoma (2 open to new patients)
• Teratoma (3 open to new patients)
• Testicular Cancer (1 open to new patients)
• Testicular Tumor (1 open to new patients)
• Thyroid Cancer (1 open to new patients)
• Thyroid Gland Medullary Carcinoma (1 open to new patients)
• Transitional Cell Carcinoma (1 open to new patients)
• Unresectable Chordoma (1 open to new patients)
• Uterine Cancer (1 open to new patients)
• Wilms Tumor (9 open to new patients)
• Wnt Positive (1 open to new patients)